Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

NCT00005928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Atherosclerosis
Coronary Disease
Vasculitis

Interventions

DRUG: Ramipril

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)